BICYCLE THERAPEUTICS PLCBCYCEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 22.90% | 10.9M | ▲ +3.00pp | 2024-12-17 |
| Deep Track Capital, LP | 9.25% | 3.5M | — | 2024-02-14 |
| NOS. OF ABOVE PERSONS | 4.70% | 2.3M | ▼ -0.30pp | 2024-11-14 |
| OF ABOVE PERSONS | 2.20% | 844.2K | — | 2024-02-14 |
| Paradigm BioCapital Advisors LP | 0.00% | 88.8M | ▼ -9.80pp | 2024-11-14 |
| Jefferies LLC | 0.00% | 88.8M | ▼ -5.17pp | 2024-11-13 |
| S.S. OR | 0.00% | — | — | 2024-02-12 |
Insider Transactions
Net 90d: −$70.0K · buys $0 / sells $70.0KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Thompson Travis Alvin | Chief Financial Officer | Sell (open market) | 102 | $5.05 | $515 |
| 2026-04-06 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell (open market) | 251 | $5.05 | $1.3K |
| 2026-04-06 | Michael Skynner | CHIEF SCIENTIFIC OFFICER | Sell (open market) | 525 | $5.05 | $2.7K |
| 2026-04-06 | Perry Jennifer Scott | Chief Operating Officer | Sell (open market) | 37 | $5.05 | $187 |
| 2026-04-06 | Perry Jennifer Scott | Chief Operating Officer | Sell (open market) | 333 | $5.04 | $1.7K |
| 2026-04-06 | Kevin Lee | CHIEF EXECUTIVE OFFICER | Sell (open market) | 1.7K | $5.05 | $8.7K |
| 2026-04-02 | Thompson Travis Alvin | Chief Financial Officer | Sell (open market) | 799 | $4.91 | $3.9K |
| 2026-04-02 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell (open market) | 1.5K | $4.91 | $7.5K |
| 2026-04-02 | Michael Skynner | CHIEF SCIENTIFIC OFFICER | Sell (open market) | 1.9K | $4.91 | $9.2K |
| 2026-04-02 | Perry Jennifer Scott | Chief Operating Officer | Sell (open market) | 1.0K | $4.91 | $5.1K |
1–10 of 11
Page 1 / 2